CD4 and colorectal carcinoma: Yamada et al.’s study [21] found that reduced CD4+T cell numbers and dysfunction in obese CRC mouse models lead to reduced anti-tumor responses of CD4+ and CD8+T cells, ultimately accelerating the progression of CRC.